Source: Pharmabiz

MaSTherCell: MaSTherCell to build new commercial manufacturing facility for cell & gene therapies

MaSTherCell S.A. a subsidiary of Masthercell Global Inc, a cell and gene therapy─dedicated contract development and manufacturing organization (CDMO) announces that it has signed a lease agreement for a 5,700m2

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
250-500
Darren Head's photo - CEO of MaSTherCell

CEO

Darren Head

CEO Approval Rating

82/100

Read more